Literature DB >> 6098258

Nucleic acid and structural proteins of infectious bursal disease virus isolates belonging to serotypes I and II.

D J Jackwood, Y M Saif, J H Hughes.   

Abstract

The nucleic acid and structural proteins of infectious bursal disease virus serotype I (six isolates) were compared with those of serotype II (two isolates). Five of the serotype I isolates originated from chickens, whereas both serotype II isolates were from turkeys. The growth curves of representative isolates of both serotypes were similar, but the latent period and virus yield were different. The seven isolates tested had two segments of double-stranded genomic RNA. The RNA migration patterns of viruses belonging to each serotype were similar, but differences were noticed between the two serotypes. There were differences in the molecular weights of viral proteins (VP) 3 and 4 from the two serotypes, and serotype II isolates lacked VP-2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098258

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  4 in total

1.  Hypericum perforatum extract therapy for chickens experimentally infected with infectious bursal disease virus and its influence on immunity.

Authors:  Ruofeng Shang; Cheng He; Jiongran Chen; Xiuying Pu; Yu Liu; Lanying Hua; Ling Wang; Jianping Liang
Journal:  Can J Vet Res       Date:  2012-07       Impact factor: 1.310

2.  Molecular weight determination of the two segments of double-stranded RNA of infectious bursal disease virus, a member of the birnavirus group.

Authors:  H Müller; R Nitschke
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

3.  Detection of infectious bursal disease viruses by using cloned cDNA probes.

Authors:  D J Jackwood; F S Kibenge; C C Mercado
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

4.  Comparison of neutralizing antigens of recent isolates of infections bursal disease virus.

Authors:  S K Reddy; A Silim
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.